Maternal obesity and inpatient medication usage

Clinical Obesity

Volumn 1, Issue 4-6, 2011, Pages 147-152

  Kennedy, C ^a   Farah, N ^a   O'Dwyer, V ^a   Hogan, J ^a   Kennelly, M ^a   Turner, M J ^a  

^a Tallaght and Coombe Women's and Infant's University Hospital   (Ireland)

Author keywords

Drug usage; Healthcare cost; Maternal obesity; Medication

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; COCODAMOL; DEXAMETHASONE; LABETALOL; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PETHIDINE; TINZAPARIN;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CAUCASIAN; CESAREAN SECTION; CHEMOPROPHYLAXIS; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INFECTION; LABOR PAIN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MATERNAL OBESITY; PAIN; PERINATAL PERIOD; PREMATURE LABOR; PRENATAL PERIOD; PRIORITY JOURNAL; PUERPERIUM; RESPIRATORY TRACT INFECTION; THROMBOSIS; URINARY TRACT INFECTION;

EID: 84886932935     PISSN: None     EISSN: 17588111     Source Type: Journal    
DOI: 10.1111/j.1758-8111.2011.00026.x     Document Type: Article

References (28)

1. World Health Organization. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. World Health Organization: Geneva, 1995.
2. Lean M, Lara J, Hill JO. ABC of obesity. Strategies for preventing obesity. BMJ 2006; 333: 959-962.
3. Kelly T, Yang W, Chen C, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32: 1431-1437.
4. World Health Organization. Obesity and overweight. 2011. URL http://www.who.int/mediacentre/factsheets/fs311/en/index. html (accessed June 2011).
5. Haslam D, Sattar N, Lean M. ABC of obesity. Obesity - time to wake up. BMJ 2006; 333: 640-642.
6. Thompson D, Wolf AM. The medical-care cost burden of obesity. Obes Rev 2001; 2: 189-197.
7. Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 2011; 12: 131-141.
8. Yu C, Teoh T, Robinson S. Obesity in pregnancy. BJOG 2006; 113: 1117-1125.
9. Heslehurst N, Simpson H, Ells LJ et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev 2008; 9: 1-49.
10. Huda S, Brodie L, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med 2010; 15: 70-76.
11. Farah N, Maher N, Barry S et al. Maternal morbid obesity and obstetric outcomes. Obes Facts 2009; 2: 352-354.
12. Weiss JL, Malone FD, Emig D et al. Obesity, obstetric complications and Cesarean delivery rate - a population-based screening study. Am J Obstet Gynecol 2004; 190: 1091-1097.
13. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004; 103: 219-224.
14. Rode L, Nilas L, Wojdemann K, Tabor A. Obesity-related complications in Danish single cephalic term pregnancies. Obstet Gynecol 2005; 105: 537-542.
15. Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy: complications and cost. Am J Clin Nutr 2000; 71 (Suppl. 5): 1242S-1248S.
16. Rowlands I, Graves N, de Jersey S, McIntyre D, Callaway L. Obesity in pregnancy: outcomes and economics. Semin Fetal Neonatal Med 2010; 15: 94-99.
17. Farah N, Stuart B, Donnelly V, Kennelly M, Turner MJ. The influence of maternal body composition on birth weight. Eur J Obstet Gynecol Reprod Biol 2011; 157: 14-17.
18. Fattah C, Farah N, Barry S et al. Maternal weight and body composition in the first trimester of pregnancy. Acta Obstet Gynecol Scand 2010; 89: 952-955.
19. Astellas Pharma. Difene Suppositories Summary of Product Characteristics. Available from URL: http://www.medicines. ie/medicine/11067/SPC/Difene+Suppositories+100mg/ (accessed June 2011).
20. Denison F, Norrie G, Graham B et al. Increased maternal BMI is associated with an increased risk of minor complications during pregnancy with consequent cost implications. BJOG 2009; 116: 1467-1472.
21. Chu S, Bachman D, Callaghan W et al. Association between obesity during pregnancy and increased use of health care. N Engl J Med 2008; 358: 1444-1453.
22. Fattah C, Farah N, O'Toole F et al. Body mass index (BMI) in women booking for antenatal care: comparison between selfreported and digital measurements. Eur J Obstet Gynecol Reprod Biol 2009; 144: 32-34.
23. Esposti ED, Sturani A, Valpiani G et al. The relationship between body weight and drug costs: an Italian population-based study. Clin Ther 2006; 28: 1472-1481.
24. Hill RK, Thompson JW, Shaw JL, Pinidiya SD, Card-Higginson P. Self-reported health risks linked to health plan cost and age group. Am J Prev Med 2009; 36: 468-474.
25. Rosenberg TJ, Garbers S, Lipkind H, Chiasson MA. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am J Public Health 2005; 95: 1545-1551.
26. Sebire NJ, Jolly M, Harris JP et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175-1182.
27. Ray JG, Vermeullen JL, Kenshole AB. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. Q J Med 2001; 94: 347-356.
28. American College of Obstetricians and Gynecologists. Fetal Macrosomia. ACOG Practice Bulletin 22. ACOG: Washington, DC, 2000.